Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function.

[1]  H. Oettgen,et al.  Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines. , 2008, Tissue antigens.

[2]  P. Marrack,et al.  The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype , 1984, The Journal of experimental medicine.

[3]  Alan F. Williams.  Immunology: The T-lymphocyte antigen receptor — elusive no more , 1984, Nature.

[4]  Mark M. Davis,et al.  Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins , 1984, Nature.

[5]  Tak W. Mak,et al.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains , 1984, Nature.

[6]  P. Doherty,et al.  The Localized Primary Cytotoxic T‐cell Response to Cells Expressing Minor Histocompatibility Differences , 1984, Scandinavian journal of immunology.

[7]  G. Maul,et al.  Tumor induction by simian virus 40 in mice is controlled by long-term persistence of the viral genome and the immune response of the host , 1984, Journal of virology.

[8]  E. Reinherz,et al.  Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes. , 1983, Science.

[9]  L. Hood,et al.  Genes of the major histocompatibility complex in mouse and man. , 1983, Science.

[10]  L. Gooding,et al.  Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. , 1983, Journal of immunology.

[11]  R. Germain,et al.  Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Fellous,et al.  Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor. , 1983, Journal of immunology.

[13]  C. Bishop,et al.  Apparent alteration in MHC antigens in K36.16, an AKR thymoma, does not result in genetic rearrangement. , 1983, Immunology.

[14]  W. Fiers,et al.  Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon , 1983, Nature.

[15]  T. Jovin,et al.  Distribution and mobility of murine histocompatibility H-2Kk antigen in the cytoplasmic membrane. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Lollini,et al.  IMPAIRED H‐2 EXPRESSION IN B 16 MELANOMA VARIANTS , 1983, Journal of immunogenetics.

[17]  D. Wilson,et al.  Epitopes on H-2Dd somatic cell mutants recognized by cytotoxic T cells , 1983, The Journal of experimental medicine.

[18]  P. Baldacci,et al.  Altered transcription of genes coding for class I histocompatibility antigens in murine tumor cells , 1983, The Journal of experimental medicine.

[19]  J. Marx.  Likely T cell receptor gene cloned. , 1983, Science.

[20]  S. Burrows,et al.  Epstein‐Barr virus specific T‐cell response in nasopharyngeal carcinoma patients , 1983, International journal of cancer.

[21]  J. Mullins,et al.  Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacs. , 1983, Science.

[22]  J. Ritz,et al.  Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas , 1983, Nature.

[23]  C. Brooks.  Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes , 1983, Nature.

[24]  J. Bluestone,et al.  Cell-surface molecules involved in T-cell functions. , 1983, Immunology today.

[25]  C. Elmets,et al.  Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation , 1983, The Journal of experimental medicine.

[26]  P. Bunn,et al.  Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus , 1983, The Journal of experimental medicine.

[27]  H. Cantor,et al.  Specificity of T cell clones for antigen and autologous major histocompatibility complex products determines specificity for foreign major histocompatibility complex products , 1983, The Journal of experimental medicine.

[28]  P. De Baetselier,et al.  Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells. , 1983, Journal of the National Cancer Institute.

[29]  G. Parmiani,et al.  H‐2K RESTRICTION OF THE T CELL‐MEDIATED LYSIS OF A CHEMICALLY‐INDUCED BALB/c FIBROSARCOMA , 1983, Journal of immunogenetics.

[30]  F. Melchers,et al.  Influenza virus site recognized by a murine helper T cell specific for H1 strains. Localization to a nine amino acid sequence in the hemagglutinin molecule , 1983, The Journal of experimental medicine.

[31]  J. Levy,et al.  ACQUIRED IMMUNODEFICIENCY SYNDROME IS AN OPPORTUNISTIC INFECTION AND KAPOSI'S SARCOMA RESULTS FROM SECONDARY IMMUNE STIMULATION , 1983, The Lancet.

[32]  G. Shearer.  Immune-deficiency syndrome (AIDS) A consequence of allogeneic Ia-antigen recognition. , 1983, Immunology today.

[33]  B. Mukherji,et al.  Clonal analysis of cytotoxic T cell response against human melanoma , 1983, The Journal of experimental medicine.

[34]  S. Segal,et al.  Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties. , 1983, Journal of the National Cancer Institute.

[35]  J. Bennink,et al.  Cross-reactivity patterns of influenza-specific cytotoxic T lymphocytes from H-2Kb mutant mice. , 1983, Journal of immunology.

[36]  R. Steinman,et al.  Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication , 1983, The Journal of experimental medicine.

[37]  E. Reinherz,et al.  Comparison of T3-associated 49- and 43-kilodalton cell surface molecules on individual human T-cell clones: evidence for peptide variability in T-cell receptor structures. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. Hood,et al.  T and B cells that recognize the same antigen do not transcribe similar heavy chain variable region gene segments , 1983, The Journal of experimental medicine.

[39]  L. Hood,et al.  Genetic mapping in the major histocompatibility complex by restriction enzyme site polymorphisms: most mouse class I genes map to the Tla complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Sandoz,et al.  Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo. , 1983, Journal of immunology.

[41]  J. Marx.  Human T-cell leukemia virus linked to AIDS. , 1983, Science.

[42]  E. Gelmann,et al.  Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS. , 1983, Science.

[43]  J. Mullins,et al.  Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. , 1983, Science.

[44]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[45]  J Leibowitch,et al.  Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). , 1983, Science.

[46]  L. Manson,et al.  Characterization of “H‐2K,D‐like structures” on MM2 × mouse L cell hybrids. II. An “H‐2Kd‐like” structure on C3H‐derived tumor , 1983, International journal of cancer.

[47]  J. Seidman,et al.  Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[48]  E. Gould,et al.  Conformational changes in Sindbis virus E1 glycoprotein induced by monoclonal antibody binding. , 1983, The Journal of general virology.

[49]  H. Fujita,et al.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin , 1983, The Journal of experimental medicine.

[50]  N. Nguyen,et al.  Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells , 1983, The Journal of experimental medicine.

[51]  A. A. Hart,et al.  Multiple genes in the H‐2 complex affect differently the number and growth rate of transplacentally induced lung tumours in mice , 1983, International journal of cancer.

[52]  L. Pease,et al.  Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Fenner,et al.  Two independent receptors allow selective target lysis by T cell clones , 1983, The Journal of experimental medicine.

[54]  R. Cotran,et al.  Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon , 1983, The Journal of experimental medicine.

[55]  J. Seidman,et al.  Hybrid H-2 histocompatibility gene products assign domains recognized by alloreactive T cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[56]  C. Uyttenhove,et al.  Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression , 1983, The Journal of experimental medicine.

[57]  A. De Rossi,et al.  Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors. , 1983, Journal of immunology.

[58]  P. Marrack,et al.  Use of somatic cell genetics to study chromosomes contributing to antigen plus I recognition by T cell hybridomas , 1983, The Journal of experimental medicine.

[59]  P. Russell,et al.  Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients. , 1983, Journal of immunology.

[60]  S. Ferrone,et al.  Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. , 1983, Cancer research.

[61]  B. Knowles,et al.  Monoclonal antibody to SV40 T-antigen blocks lysis of cloned cytotoxic T-cell line specific for SV40 TASA. , 1983, Virology.

[62]  A. Svejgaard,et al.  HLA and Disease 1982 ‐ A Survey , 1983, Immunological reviews.

[63]  G. Parmiani,et al.  Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells. , 1983, Journal of the National Cancer Institute.

[64]  J. Dausset,et al.  HLA and Susceptibility to Hodgkin's Disease , 1983, Immunological reviews.

[65]  P. Stastny,et al.  The Human Immune Response Region (HLA‐D) and Disease Susceptibility , 1983, Immunological reviews.

[66]  A. Campbell,et al.  Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cytotoxic T lymphocyte clones. , 1983, Journal of immunology.

[67]  K. Rock,et al.  The role of Ia molecules in the activation of T lymphocytes. III. Antigen-specific, Ia-restricted, interleukin 2-producing T cell hybridomas with detectable affinity for the restricting I-A molecule , 1983, The Journal of experimental medicine.

[68]  S. Burakoff,et al.  Stimulation of secondary anti-MSV cytolytic T lymphocytes with MBL-2 reconstituted membranes. , 1983, Journal of immunology.

[69]  Irving L. Weissman,et al.  Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells , 1983, The Journal of experimental medicine.

[70]  J. Allison,et al.  Biochemical evidence for expression of a semi-allogeneic, H-2 antigen by a murine adenocarcinoma. , 1983, Journal of immunology.

[71]  L. Hood,et al.  DNA sequence of the gene encoding the E alpha Ia polypeptide of the BALB/c mouse. , 1982, Science.

[72]  J. Skehel,et al.  Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins , 1982, Nature.

[73]  J. Jensenius,et al.  The T lymphocyte antigen receptor—paradigm lost , 1982, Nature.

[74]  D. Kemp,et al.  A search for messenger RNA molecules bearing immunoglobulin VH nucleotide sequences in T cells , 1982, The Journal of experimental medicine.

[75]  M. Reitz,et al.  Human retroviruses and adult T-cell leukemia-lymphoma. , 1982, Journal of the National Cancer Institute.

[76]  S. S. Yang,et al.  Effect of interleukin 2 on cytotoxic effectors: I. short‐term culture of the cytotoxic effectors and the in vivo anti‐tumor activity of the cultured effectors isolated from tumor site , 1982, International journal of cancer.

[77]  J. Woody,et al.  Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin , 1982, Nature.

[78]  M. Lipinski,et al.  Monoclonal antibody defining a Burkitt's lymphoma-associated antigen detects carbohydrate on neutral glycolipid. , 1982, Journal of immunology.

[79]  J. Allison,et al.  Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. , 1982, Journal of immunology.

[80]  M. Fellous,et al.  Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells , 1982, Nature.

[81]  C. Auffray,et al.  The amino acid sequence and gene organization of the heavy chain of the HLA-DR antigen: homology to immunoglobulins. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[82]  J. Kaufman,et al.  HLA‐DR Antigens: Structure, Separation of Subpopulations, Gene Cloning and Function , 1982, Immunological reviews.

[83]  L. Gooding.  Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk. , 1982, Journal of Immunology.

[84]  R. Kerbel,et al.  Abrogation of the in vitro generation of the cytotoxic T‐cell response to a murine tumor: The role of suppressor cells , 1982, International journal of cancer.

[85]  D. Longo,et al.  The fine specificity of antigen and la determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c , 1982, Cell.

[86]  R. Elliott,et al.  Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[87]  A. Yu,et al.  T helper cells in immune mice amplify the primary anti-tumor cytotoxic response. , 1982, Journal of immunology.

[88]  D. Larhammar,et al.  Alpha chain of HLA-DR transplantation antigens is a member of the same protein superfamily as the immunoglobulins , 1982, Cell.

[89]  J. Kaufman,et al.  HLA-DR light chain has a polymorphic N-terminal region and a conserved immunoglobulin-like C-terminal region , 1982, Nature.

[90]  N. Cascinelli,et al.  HLA complex and familial malignant melanoma , 1982, International journal of cancer.

[91]  H. Orr,et al.  Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[92]  P. Marrack,et al.  Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[93]  S. Zolla-Pazner,et al.  Disseminated Kaposi's sarcoma in homosexual men. , 1982, Annals of internal medicine.

[94]  A. Fauci.  The syndrome of Kaposi's sarcoma and opportunistic infections: an epidemiologically restricted disorder of immunoregulation. , 1982, Annals of internal medicine.

[95]  E. Klein,et al.  Specificity of auto‐tumor cytotoxicity exerted by fresh, activated and propagated human t lymphocytes , 1982, International journal of cancer.

[96]  M. Lubeck,et al.  Conformational changes at topologically distinct antigenic sites on the influenza A/PR/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. , 1982, Virology.

[97]  L. Hood,et al.  Genes of the major histocompatibility complex , 1982, Cell.

[98]  F. Plata.  Specificity studies on cytolytic T lymphocytes directed against murine leukemia virus-induced tumors. Analysis of monoclonal cytolytic T lymphocytes , 1982, The Journal of experimental medicine.

[99]  J. Butel,et al.  Detection of simian virus 40 surface‐associated large tumor antigen by enzyme‐catalyzed radioiodination , 1982, International journal of cancer.

[100]  M. Colombo,et al.  Cross‐reactions between tumor cells and allogeneic normal tissues. inhibition of a syngeneic lymphoma outgrowth in h‐2 and non‐h‐2 alloimmune balb/c mice , 1982, International journal of cancer.

[101]  J. Bennink,et al.  A monoclonal antibody to an interspecies major histocompatibility determinant inhibits a virus-specific T-cell clone. , 1982, Cellular immunology.

[102]  W G Laver,et al.  Molecular mechanisms of variation in influenza viruses , 1982, Nature.

[103]  J. Yewdell,et al.  A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone , 1982, Nature.

[104]  J. Seidman,et al.  Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[105]  L. Hood,et al.  Clusters of genes encoding mouse transplantation antigens , 1982, Cell.

[106]  L. Sherman.  Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes , 1982, The Journal of experimental medicine.

[107]  C. Janeway,et al.  Immune response gene function correlates with the expression of an Ia antigen. II. A quantitative deficiency in A(e):E(a), complex expression causes a corresponding defect in antigen-presenting cell function , 1982, The Journal of experimental medicine.

[108]  P. Doherty,et al.  Limiting dilution analysis of the specificity of influenza-immune cytotoxic T cells. , 1982, Cellular immunology.

[109]  J. Berzofsky,et al.  Genetic control of the immune response to myoglobins. VI. Distinct Ir genes for different myoglobins: complementing genes in I-A and H-2D for equine myoglobin. , 1982, Journal of immunology.

[110]  M. Greene,et al.  Specific thymus-derived (T) cell recognition of papova virus-transformed cells. , 1982, Journal of immunology.

[111]  C. Janeway,et al.  Immune response gene function correlates with the expression of an Ia antigen. I. Preferential association of certain Ae and E alpha chains results in a quantitative deficiency in expression of an Ae:E alpha complex , 1982, The Journal of experimental medicine.

[112]  J. Giorgi,et al.  Tumor immunity to murine plasma cell tumors. VII. Expression of H-2 and tumor antigens on Ig synthesis variants of MPC-11. , 1982, International journal of cancer.

[113]  G. Bonnard,et al.  Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2 , 1982, International journal of cancer.

[114]  B. Askonas,et al.  Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell , 1982, Nature.

[115]  M. Bevan,et al.  Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis , 1982, The Journal of experimental medicine.

[116]  P. Wettstein,et al.  H-2Kb mutations limit the CTL response to SV40 TASA. , 1982, Journal of immunology.

[117]  D. Lannin,et al.  H-2 restriction of the T cell response to chemically induced tumors: evidence from F1 replaced by parent chimeras. , 1982, Journal of immunology.

[118]  D. Durack.  Opportunistic infections and Kaposi's sarcoma in homosexual men. , 1981, The New England journal of medicine.

[119]  M. Gottlieb,et al.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981, The New England journal of medicine.

[120]  J. Levy,et al.  Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice. , 1981, Journal of immunology.

[121]  H. Festenstein,et al.  Variation in MHC Antigenic Profiles of Tumor Cells and its Biological Effects , 1981, Immunological reviews.

[122]  J. Levy,et al.  Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes , 1981, The Journal of experimental medicine.

[123]  J. Moorhead.  Antigen receptors on murine T lymphocytes in contact sensitivity. I. Functional inhibition of effector T cells by monovalent 2,4- dinitrophenol: implication for a two-receptor model , 1981, The Journal of experimental medicine.

[124]  E. Walker,et al.  Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cells by B lymphocyte tumor cells , 1981, The Journal of experimental medicine.

[125]  J. Ortaldo,et al.  Natural killer cells: their roles in defenses against disease. , 1981, Science.

[126]  J. Dennis,et al.  Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants. , 1981, Cancer research.

[127]  P. Doherty,et al.  Development and Loss of Virus‐Specific Thymic Competence in Bone Marrow Radiation Chimeras and Normal Mice , 1981, Immunological reviews.

[128]  P. M. Long,et al.  Serologic and biochemical identification of minor histocompatibility (H-4) antigens. , 1981, Journal of immunology.

[129]  K. Rosenthal,et al.  Experiments and Speculation on Antiviral Specificity of T and B Cells , 1981, Immunological reviews.

[130]  H. Ertl,et al.  An Analysis of Effector T Cell Generation and Function in Mice Exposed to Influenza A or Sendai Viruses , 1981, Immunological reviews.

[131]  P. Matzinger.  A one-receptor view of T-cell behaviour , 1981, Nature.

[132]  S. Ferrone,et al.  HLA-A,B antigens Ia-like antigens, and tumor-associated antigens on prostate carcinoma cell lines: serologic and immunochemical analysis with monoclonal antibodies. , 1981, Journal of immunology.

[133]  H. Snodgrass,et al.  T lymphocytes specific for immunoglobulin allotype. II. Cloned Igh-1(b)- specific cytotoxic T cells , 1981, The Journal of experimental medicine.

[134]  H. Macdonald,et al.  Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors , 1981, The Journal of experimental medicine.

[135]  H. Mcdevitt.  THE ROLE OF H‐2 I REGION GENES IN REGULATION OF THE IMMUNE RESPONSE * , 1981, Journal of immunogenetics.

[136]  S. Rosenberg,et al.  Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens. , 1981, Journal of immunology.

[137]  D. Green,et al.  Contrasuppression. A novel immunoregulatory activity , 1981, The Journal of experimental medicine.

[138]  M. Poupon,et al.  Adoption of tumor immunity: role of the major histocompatibility complex. , 1981, Journal of immunology.

[139]  P. Greenberg,et al.  H-2 restriction of adoptive immunotherapy of advanced tumors. , 1981, Journal of immunology.

[140]  D. Nelson,et al.  Cancer and subversion of host defences. , 1981, The Australian journal of experimental biology and medical science.

[141]  J. Fogh,et al.  HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines. , 1981, Journal of the National Cancer Institute.

[142]  D. Baltimore.  Gene conversion: Some implications for immunoglobulin genes , 1981, Cell.

[143]  T. Kindt,et al.  Primary structure of a murine transplantation antigen , 1981, Nature.

[144]  P. Marrack,et al.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition , 1981, The Journal of experimental medicine.

[145]  T. Braciale,et al.  Simultaneous expression of H-2-restricted and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T lymphocytes , 1981, The Journal of experimental medicine.

[146]  V. Quaranta,et al.  Ia-like antigens on freshly explanted human melanoma. , 1981, Clinical immunology and immunopathology.

[147]  J. Yewdell,et al.  Expression of influenza A virus internal antigens on the surface of infected P815 cells. , 1981, Journal of immunology.

[148]  S. Tonegawa,et al.  Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes , 1981, Nature.

[149]  T. Braciale,et al.  Heterogeneity and specificity of cloned lines of influenza-virus specific cytotoxic T lymphocytes , 1981, The Journal of experimental medicine.

[150]  C. Lutz,et al.  Murine T Lymphocyte Clones with Distinct Immunological Functions , 1981, Immunological reviews.

[151]  L. Lanier,et al.  Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line:analysis by flow cytometry. , 1981, Journal of immunology.

[152]  A. Weiss,et al.  Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction. , 1981, Journal of immunology.

[153]  H. Boehmer,et al.  H‐2 Restricted Cytolytic and Noncytolytic T Cell Clones: Isolation, Specificity and Functional Analysis , 1981, Immunological reviews.

[154]  J. Bennink,et al.  Negatively selected H-2bml and H-2b cells stimulated with vaccinia virus completely discriminate between mutant and wild-type H-2K alleles. , 1981, Journal of immunology.

[155]  C. Croce,et al.  Expression of H–2, laminin and SV40T and TASA on differentiation of transformed murine teratocarcinoma cells , 1980, Nature.

[156]  W. Green.  H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen. , 1980, Journal of immunology.

[157]  S. Segal,et al.  Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties , 1980, Nature.

[158]  J. Streilein,et al.  Ia antigens and epidermal Langerhans cells. , 1980, Transplantation.

[159]  P. Jokiel,et al.  CHARACTERISTICS OF TRANSPLANTATION IMMUNITY IN THE SPONGE, CALLYSPONGIA DIFFUSA , 1980, Transplantation.

[160]  A. Weiss,et al.  Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens , 1980, The Journal of experimental medicine.

[161]  J. Roder,et al.  Do NK cells play a role in anti-tumor surveillance? , 1980, Immunology today.

[162]  W. Duncan,et al.  IMMUNOGENETIC RELATIONSHIPS AMONG GENETICALLY DEFINED, INBRED DOMESTIC SYRIAN HAMSTER STRAINS , 1980, Transplantation.

[163]  Richard G. Miller.  An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it , 1980, Nature.

[164]  J. Bennink,et al.  An Examination of MHC Restriction in the Context of a Minimal Clonal Abortion Model for Tolerance , 1980, Scandinavian journal of immunology.

[165]  P. Jokiel,et al.  ALLOGENEIC POLYMORPHISM AND ALLOIMMUNE MEMORY IN THE CORAL, MONTIPORA VERRUCOSA , 1980, Transplantation.

[166]  S. Emerson,et al.  Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2- restricted recognition , 1980, The Journal of experimental medicine.

[167]  E. Rüde,et al.  T cell factor (interleukin 2) allows in vivo induction of T helper cells against heterologous erythrocytes in athymic (nu/nu) mice , 1980, European journal of immunology.

[168]  M. Bevan,et al.  Specificity of cytotoxic T cells from athymic mice , 1980, The Journal of experimental medicine.

[169]  B. Chesebro,et al.  Cytotoxic T lymphocyte recognition of gp70 on Friend virus-induced erythroleukemia cell clones. , 1980, Journal of immunology.

[170]  W. Green,et al.  Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. , 1980, Journal of immunology.

[171]  P Parham,et al.  Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies. , 1980, The Journal of experimental medicine.

[172]  J. Howard.  MHC restriction, self-tolerance and the thymus , 1980, Nature.

[173]  R. Maizels,et al.  Epitope specificity of the T cell proliferative response to lysozyme: proliferative T cells react predominantly to different determinants from those recognized by B cells , 1980, European journal of immunology.

[174]  D. Harris,et al.  Elicitation of anti-viral cytotoxic T lymphocytes with purified viral and H-2 antigens. , 1980, Journal of immunology.

[175]  J. H. Pope,et al.  HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[176]  L. Sherman.  Dissection of the B10.D2 anti-H-2Kb cytolytic T lymphocyte receptor repertoire , 1980, The Journal of experimental medicine.

[177]  R. Webster,et al.  Quantitation of influenza virus antigens on infected target cells and their recognition by cross-reactive cytotoxic T cells , 1980, The Journal of experimental medicine.

[178]  C. Melief,et al.  Fine specificity of alloimmune cytotoxic T lymphocytes directed against H-2K. A study with Kb mutants , 1980, The Journal of experimental medicine.

[179]  M. Bevan,et al.  Self H-2 antigens influence the specificity of alloreactive cells , 1980, The Journal of experimental medicine.

[180]  L. Gooding,et al.  Solubilization of complexes between tumor‐associated and H‐2 antigens from a tumor cell plasma membrane , 1980, European journal of immunology.

[181]  K. Pfizenmaier,et al.  Preferential H-2 association in cytotoxic T cell responses to SV40 tumor-associated specific antigens. , 1980, Journal of immunology.

[182]  M. Röllinghoff,et al.  Fine Specificity and Cytolytic Activity of Continuously Growing Alloreactive Cytotoxic T Lymphocyte Clones , 1980, Scandinavian journal of immunology.

[183]  M. Gething,et al.  Recognition of viral glycoproteins by influenza A-specific cross- reactive cytolytic T lymphocytes , 1980, The Journal of experimental medicine.

[184]  M. Epstein,et al.  HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells , 1980, Nature.

[185]  D. Meruelo.  H‐2D CONTROL OF LEUKAEMIA SUSCEPTIBILITY: MECHANISM AND IMPLICATIONS * , 1980, Journal of immunogenetics.

[186]  G. Shearer,et al.  The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes. , 1980, Journal of immunology.

[187]  D. Thorley-Lawson.  The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. , 1980, Journal of immunology.

[188]  R. Strong,et al.  Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. , 1980, Surgery.

[189]  R. Webster,et al.  Monoclonal antibodies to hemagglutinin and to H‐2 inhibit the cross‐reactive cytotoxic T cell populations induced by influenza , 1980, European journal of immunology.

[190]  F. Bach,et al.  Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells. , 1980, Journal of immunology.

[191]  R. North,et al.  T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor , 1980, The Journal of experimental medicine.

[192]  R. Doll,et al.  Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. , 1979, British medical journal.

[193]  H. Besedovsky,et al.  Role of prethymic cells in acquisition of self-tolerance , 1979, The Journal of experimental medicine.

[194]  F. Plata,et al.  Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus , 1979, The Journal of experimental medicine.

[195]  P. Doherty,et al.  Inhibition of influenza-immune T cell effector function by virus-specific hybridoma antibody. , 1979, Journal of immunology.

[196]  K. F. Lindahl,et al.  Inhibition of killer‐target cell interaction by monoclonal anti‐H‐2 antibodies , 1979, European journal of immunology.

[197]  S. Burakoff,et al.  The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes. , 1979, Journal of immunology.

[198]  R. Ashman,et al.  Different D end-dependent antigenic determinants are recognized by H-2- restricted cytotoxic T cells specific for influenza and Bebaru viruses , 1979, The Journal of experimental medicine.

[199]  M. Guslandi,et al.  GASTRIC CANCER IN PATIENTS WHO HAVE TAKEN CIMETIDINE , 1979, The Lancet.

[200]  F. Plata,et al.  Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes , 1979, The Journal of experimental medicine.

[201]  D. Solter,et al.  Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen. , 1979, Journal of immunology.

[202]  I. Weissman,et al.  Moloney virus-induced cell surface antigens and histocompatibility antigens are located on distinct molecules. , 1979, Journal of immunology.

[203]  G. Klein.  Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[204]  C. Ting,et al.  Studies of the mechanisms for the induction of in vivo tumor immunity. VII. Development of specific antitumor immunity in progressors and regressors , 1979, International journal of cancer.

[205]  A. Senik,et al.  Association between H-2 and vaccinia virus-induced antigens on the surface of infected cells. , 1979, Journal of immunology.

[206]  D. Meruelo,et al.  A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes , 1979, The Journal of experimental medicine.

[207]  C. Riccardi,et al.  Natural Killer Cells: Characteristics and Regulation of Activity , 1979, Immunological reviews.

[208]  J. Chiller,et al.  Lymphocyte specificity to protein antigens. II. Fine specificity of T- cell activation with cytochrome c and derived peptides as antigenic probes , 1979, The Journal of experimental medicine.

[209]  D. Livingston,et al.  Relationship between T-antigen and tumor-specific transplantation antigen in simian virus 40-transformed cells , 1979, Journal of virology.

[210]  P. Doherty,et al.  Vaccinia-specific cytotoxic T-cell responses in the context of H-2 antigens not encountered in thymus may reflect aberrant recognition of a virus-H-2 complex , 1979, The Journal of experimental medicine.

[211]  J. Allison,et al.  Physical association of histocompatibility antigens and tumor-associated antigens on the surface of murine lymphoma cells. , 1979, Journal of immunology.

[212]  R. Finberg,et al.  The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins , 1978, The Journal of experimental medicine.

[213]  C. Y. Wang,et al.  Expression of Ia-like antigens on cultured human malignant melanoma cell lines. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[214]  P. Fink,et al.  The Influence of Thymus H‐2 Antigens on the Specificity of Maturing Killer and Helper Cells , 1978, Immunological reviews.

[215]  H. Waldmann.  The Influence of the Major Histocompatibility Complex on the Function of T‐Helper Cells in Antibody Formation , 1978, Immunological reviews.

[216]  I. Keshet,et al.  Association of Mouse Major Histocompatibility and Rauscher Murine Leukaemia Virus Envelope Glycoprotein Antigens on Leukaemia Cells and their Recognition by Syngeneic Virus‐Immune‐Cytotoxic T‐Lymphocytes , 1978, Scandinavian journal of immunology.

[217]  R. Zinkernagel.  Thymus and Lymphohemopoietic Cells: Their Role in T Cell Maturation in Selection of T Cells' H‐2‐Restriction‐Specificity and in H‐2 Linked Ir Gene Control , 1978, Immunological reviews.

[218]  R. Kerbel,et al.  Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low‐metastatic H‐2 heterozygous tumor cell line into an H‐2 incompatible parental strain , 1978, International journal of cancer.

[219]  O. Stutman,et al.  H–2 restriction and non-restriction of T-cell-mediated cytotoxicity against mouse mammary tumour targets , 1978, Nature.

[220]  P. A. Peterson,et al.  Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[221]  M. Greaves,et al.  Patterns of gene expression and the cellular origins of human leukaemias. , 1978, Biochimica et biophysica acta.

[222]  B. Benacerraf,et al.  Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[223]  H. Mcdevitt,et al.  Two-gene control of the expression of a murine Ia antigen , 1978, The Journal of experimental medicine.

[224]  A. McMichael,et al.  Influenza virus‐specific cytotoxic T cells in man; induction and properties of the cytotoxic cell , 1978, European journal of immunology.

[225]  Y. Kaneko,et al.  Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL. , 1978, Journal of immunology.

[226]  J. Klein,et al.  Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness , 1978, The Journal of experimental medicine.

[227]  J. Bennink,et al.  Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype , 1978, The Journal of experimental medicine.

[228]  W. Martin,et al.  HISTOCOMPATIBILITY DIFFERENCE BETWEEN C3HfeB/HeN AND C3H/HeN MICE: TUMOUR INDUCED IN C3HfeB/HeN MICE EXPRESSES C3H/HeN‐ASSOCIATED ALLOANTIGEN , 1978, Journal of immunogenetics.

[229]  W. Paul,et al.  Interaction Between Antigen‐Presenting Cells and Primed T Lymphocytes , 1978, Immunological reviews.

[230]  F. Bach,et al.  Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells , 1978, Nature.

[231]  M. Herlyn,et al.  Study of antibodies against human melanoma produced by somatic cell hybrids. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[232]  B. Benacerraf.  Opinion A Hypothesis to Relate the Specificity of T Lymphocytes and the Activity of I Region-Specific Ir Genes in Macrophages and B Lymphocytes , 1978 .

[233]  M. Edidin,et al.  Effect of the H-2 gene complex rates of fibroblast intercellular adhesion , 1978, The Journal of cell biology.

[234]  S. Singer,et al.  Participation of histocompatibility antigens in capping of molecularly independent cell surface components by their specific antibodies. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[235]  T. Rème,et al.  Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirusinduced tumors , 1978, European journal of immunology.

[236]  Suzie Chen,et al.  Nonrandom inclusion of H-2K and H-2D antigens in Friend virus particles from mice of various strains , 1978, The Journal of experimental medicine.

[237]  D. Meruelo,et al.  Increased synthesis and expression of H-2 antigens on thymocytes as a result of radiation leukemia virus infection: a possible mechanism for H-2 linked control of virus-induced neoplasia , 1978, The Journal of experimental medicine.

[238]  R. Schwartz.  A Clonal Deletion Model for Ir Gene Control of the Immune Response , 1978, Scandinavian journal of immunology.

[239]  J. Forman,et al.  Immunogenetic analysis of H-2 mutations - VI. Crossreactivity in cell-mediated lympholysis between TNP-modified cells from H-2 mutant strains , 1977 .

[240]  J. Frelinger,et al.  H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. II. H-2 D region control of H-7.1-specific stimulator function in mixed lymphocyte culture and susceptibility to lysis by H-7.1- specific cytotoxic cells , 1977, The Journal of experimental medicine.

[241]  K. Blank,et al.  Evidence for an H–2/viral protein complex on the cell surface as the basis for the H–2 restriction of cytotoxicity , 1977, Nature.

[242]  C. Y. Wang,et al.  Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[243]  J. H. Pope,et al.  An immunological basis for inhibition of transformation of human lymphocytes by EB virus , 1977, Nature.

[244]  J. Strominger,et al.  Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes , 1977, The Journal of experimental medicine.

[245]  S. Russell,et al.  Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas. , 1977, Journal of immunology.

[246]  J. Forman.  Cytotoxic T cells distinguish between trinitrophenyl- and dinitrophenyl- modified syngeneic cells , 1977, The Journal of experimental medicine.

[247]  H. Snodgrass,et al.  Induction of virus-specific modifications recognized by cytotoxic T cells is not altered by prior substitution of target cells with trinitrophenol , 1977, The Journal of experimental medicine.

[248]  R. J. Cohen,et al.  Interactions of macromolecules on cell membranes and restrictions of T-cell specificity by products of the major histocompatibility complex☆ , 1977 .

[249]  E. Simpson,et al.  Responsiveness to HY Antigen Ir Gene Complementation and Target Cell Specificity , 1977, Immunological reviews.

[250]  J. Skehel,et al.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses , 1977, Nature.

[251]  M. Bevan.  Killer cells reactive to altered-self antigens can also be alloreactive. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[252]  F. Garrido,et al.  IMMUNOGENETIC STUDIES ON METH‐A‐VACCINIA TUMOUR CELLS IN VIVO AND IN VITRO * , 1977, Journal of immunogenetics.

[253]  D. Solter,et al.  H–2 gene expression is required for T cell-mediated lysis of virus-infected target cells , 1977, Nature.

[254]  M. Barcinski,et al.  Immune response gene control of determinant selection. I. Intramolecular mapping of the immunogenic sites on insulin recognized by guinea pig T and B cells , 1977, The Journal of experimental medicine.

[255]  L. Gooding.  Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells. , 1977, Journal of immunology.

[256]  J. Bennink,et al.  Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses , 1977, The Journal of experimental medicine.

[257]  D. Hart,et al.  Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. II. Correlation between derivatization of H-2 antigens with trinitrophenyl and the ability of trinitrophenyl-modified cells to react functionally to the CML assay. , 1977, Journal of immunology.

[258]  P. Doherty,et al.  Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[259]  J. Oxford,et al.  Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells , 1977, Nature.

[260]  J. Rice,et al.  H–2a-associated alloantigen expressed by several transplacentally-induced lung tumours of C3Hf mice , 1977, Nature.

[261]  P. Palese.  The genes of influenza virus , 1977, Cell.

[262]  M. Oldstone,et al.  Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[263]  B. Chesebro,et al.  Characterization of Ia8 antigen, thy-1.2 antigen, complement receptors, and virus production in a group of murine virus-induced leukemia cell lines. , 1976, Journal of immunology.

[264]  D. Summers,et al.  Interactions of vesicular stomatitis virus with murine cell surface antigens , 1976, Journal of virology.

[265]  C. Janeway,et al.  Two Different VH Gene Products Make Up the T‐Cell Receptors , 1976, Scandinavian journal of immunology.

[266]  M. Bevan.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay , 1976, The Journal of experimental medicine.

[267]  E. Shevach,et al.  Mutant lines of guinea pig L2C leukemia. I. Deletion of Ia alloantigens is associated with a loss in immunogenicity of tumor-associated transplantation antigens , 1976, The Journal of experimental medicine.

[268]  M. Greene,et al.  The genetic and cellular basis of regulation of the immune response to tumor antigens. , 1976, Contemporary topics in immunobiology.

[269]  R. Zinkernagel.  H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. The H-2K structure involved is coded by a single cistron defined by H-2Kb mutant mice , 1976, The Journal of experimental medicine.

[270]  R. Germain,et al.  Inhibition of cell-mediated cytolysis of trinitrophenyl-derivatized target cells by alloantisera directed to the products of the K and D loci of the H-2 complex. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[271]  B. Chesebro,et al.  Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity , 1976, The Journal of experimental medicine.

[272]  G. Edelman,et al.  Functional interactions of viral and histocompatibility antigens at tumor cell surfaces. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[273]  L. Samelson,et al.  In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice , 1975, The Journal of experimental medicine.

[274]  E. Vitetta,et al.  Absence of H-2 antigens capable of reacting with cytotoxic T cells on a teratoma line expressing a T/t locus antigen. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[275]  M. Bevan.  Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier , 1975, Nature.

[276]  R. Zinkernagel,et al.  A BIOLOGICAL ROLE FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS , 1975, The Lancet.

[277]  R. Zinkernagel,et al.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T- cell specificities are associated with structures coded for in H-2K or H-2D; , 1975, The Journal of experimental medicine.

[278]  A. Allison,et al.  Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice , 1974, Nature.

[279]  B. Chesebro,et al.  HOST GENETIC CONTROL OF RECOVERY FROM FRIEND LEUKEMIA VIRUS-INDUCED SPLENOMEGALY , 1974, The Journal of experimental medicine.

[280]  A. Goldstein,et al.  Requirement of Thymus-Derived θ-Positive Lymphocytes for Rejection of DNA Virus (SV40) Tumors in Mice , 1974, The Journal of Immunology.

[281]  R. Zinkernagel,et al.  Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis , 1974, Nature.

[282]  G. Shearer,et al.  Cell‐mediated cytotoxicity to trinitrophenyl‐modified syngeneic lymphocytes , 1974, European journal of immunology.

[283]  K. Artzt,et al.  Letter: Absence of serologically detectable H-2 on primitive teratocarcinoma cells in culture. , 1974, Transplantation.

[284]  R. Zinkernagel,et al.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.

[285]  W. Bodmer.  New genetic model for allelism at histocompatibility and other complex loci: polymorphism for control of gene expression. , 1973, Transplantation proceedings.

[286]  F. Burnet.  Multiple Polymorphism in Relation to Histocompatibility Antigens , 1973, Nature.

[287]  A. Sehon,et al.  Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice. , 1973, Journal of immunology.

[288]  B. Rouse,et al.  Proportion of T and B lymphocytes in lesions of Marek's disease: theoretical implications for pathogenesis. , 1973, Journal of immunology.

[289]  W. Bodmer,et al.  Evolutionary Significance of the HL-A System , 1972, Nature.

[290]  H. Mcdevitt,et al.  Histocompatibility-linked immune response genes. , 1972, Science.

[291]  C. Mckhann,et al.  ANTIGENIC SPECIFICITIES ON MURINE SARCOMA CELLS , 1971, The Journal of experimental medicine.

[292]  G. Klein,et al.  Antigenic characterization of heterozygous mouse lymphomas after immunoselection in vivo. , 1968, Journal of the National Cancer Institute.

[293]  F. Lilly,et al.  THE EFFECT OF HISTOCOMPATIBILITY-2 TYPE ON RESPONSE TO THE FRIEND LEUKEMIA VIRUS IN MICE , 1968, The Journal of experimental medicine.

[294]  Darcy B. Wilson,et al.  QUANTITATIVE STUDIES ON THE MIXED LYMPHOCYTE INTERACTION IN RATS , 1967, The Journal of experimental medicine.

[295]  D. Bailey,et al.  Inherited histocompatibility changes in progeny of irradiated and unirradiated inbred mice. , 1965, Genetical research.

[296]  G. Klein,et al.  Histocompatibility changes in tumors. , 1958, Journal of cellular physiology. Supplement.

[297]  R. Barth,et al.  Strong and Weak Histocompatibility Gene Differences in Mice and Their Role in the Rejection of Homografts of Tumors and Skin , 1956, Annals of surgery.

[298]  R. Prehn.  The dose-response curve in tumor-immunity. , 1983, International journal of immunopharmacology.

[299]  D. Faller,et al.  Cytotoxic T lymphocyte recognition of transfected cells expressing a cloned retroviral gene , 1983, Nature.

[300]  A. Eb,et al.  Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells , 1983, Nature.

[301]  C. Melief,et al.  Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity , 1983, Nature.

[302]  V. E. Williams,et al.  Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[303]  L R Pease,et al.  Spontaneous H-2 mutants provide evidence that a copy mechanism analogous to gene conversion generates polymorphism in the major histocompatibility complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[304]  R. Ashman,et al.  Cytotoxic T-memory cells in virus infection and the specificity of helper T cells. , 1982, Immunology.

[305]  W. Bodmer,et al.  cDNA clones coding for the heavy chain of human HLA-DR antigen. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[306]  G. Klein,et al.  Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. , 1982, Advances in cancer research.

[307]  J. Klein,et al.  Mhc restriction and Ir genes. , 1982, Advances in cancer research.

[308]  K. Rajewsky,et al.  Isolation of a cloned cell line expressing variant H–2Kk using fluorescence-activated cell sorting , 1981, Nature.

[309]  T. Kindt,et al.  Primary structural: analysis of the transplantation antigens of the murine H-2 major histocompatibility complex. , 1981, Annual review of biochemistry.

[310]  B. Hampar.  Transformation induced by herpes simplex virus: a potentially novel type of virus-cell interaction. , 1981, Advances in cancer research.

[311]  D. Purtilo,et al.  Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. , 1981, Advances in cancer research.

[312]  M. Kripke.  Immunologic mechanisms in UV radiation carcinogenesis. , 1981, Advances in cancer research.

[313]  J. Kreider,et al.  The Shope papilloma-carcinoma complex of rabbits: a model system of neoplastic progression and spontaneous regression. , 1981, Advances in cancer research.

[314]  M. Greaves,et al.  Exploitation of monoclonal antibodies: a "who's who" of haemopoietic malignancy. , 1981, Blood cells.

[315]  S. Nathenson,et al.  Biochemistry of the gene products from murine MHC mutants. , 1980, Annual review of genetics.

[316]  J. M. Phillips-Quagliata.  Thymus dependency of neonatal tolerance induction in the absence of detectable suppressor cells. , 1980, Cellular immunology.

[317]  H. Hausen.  The role of viruses in human tumors. , 1980 .

[318]  K. Pfizenmaier,et al.  The role of the major histocompatibility gene complex in murine cytotoxic T cell responses. , 1980, Advances in cancer research.

[319]  J. Miller,et al.  Influence of the major histocompatibility complex on T-cell activation. , 1979, Advances in cancer research.

[320]  D. Naor.  Suppressor cells: permitters and promoters of malignancy? , 1979, Advances in cancer research.

[321]  R M Zinkernagel,et al.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. , 1979, Advances in immunology.

[322]  D. Gershon,et al.  Of feedback inhibition in vivo. Absence in nzb mice. , 1978 .

[323]  J. Klein,et al.  H-2 mutations: their genetics and effect on immune functions. , 1978, Advances in immunology.

[324]  R. Langman,et al.  Cell-mediated immunity and the major histocompatibility complex. , 1978, Reviews of physiology, biochemistry and pharmacology.

[325]  K. Eichmann.  Expression and function of idiotypes of lymphocytes. , 1978, Advances in immunology.

[326]  R. Herberman,et al.  Natural cell-mediated immunity. , 1978, Advances in cancer research.

[327]  H. Binz,et al.  Antigen-binding, idiotypic T-lymphocyte receptors. , 1977, Contemporary topics in immunobiology.

[328]  J. Mark.  Chromosomal abnormalities and their specificity in human neoplasms: an assessment of recent observations by banding techniques. , 1977, Advances in cancer research.

[329]  G. Shearer,et al.  Major histocompatibility complex restricted cell-mediated immunity. , 1977, Advances in immunology.

[330]  J. Levy,et al.  The murine sarcoma virus-induced tumor: exception or general model in tumor immunology? , 1977, Advances in cancer research.

[331]  R. Germain,et al.  Cytolytic thymus-derived lymphocytes specific for allogeneic stimulator cells crossreact with chemically modified syngeneic cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[332]  R. Prehn.  Tumor progression and homeostasis. , 1976, Advances in cancer research.

[333]  H. Mcdevitt,et al.  The Histocompatibility-Linked Immune Response Genes , 1975 .

[334]  Lawrence Hs.  Transfer factor in cellular immunity. , 1974 .

[335]  R. Gershon.  T cell control of antibody production. , 1974, Contemporary topics in immunobiology.

[336]  T. Pincus,et al.  Genetic Control Of Murine Viral Leukemogenesis , 1973 .

[337]  N. K. Jerne,et al.  The somatic generation of immune recognition , 1971, European journal of immunology.

[338]  H. Mcdevitt,et al.  Genetic control of specific immune responses. , 1969, Advances in immunology.

[339]  M. Simonsen.  The Clonal Selection Hypothesis Evaluated by Grafted Cells Reacting Against their Hosts , 1967 .